Harell Data Debuts with $15M to Change Incentives for AI Drug Discovery

Bellevue-based Harell Data has launched with $15M in funding to develop a new business model that enables data generators to share in the value created from AI-assisted drug discovery. Founded by Harlan Robins, scientific founder of Seattle’s Adaptive Biotechnologies, the company aims to create a more sustainable ecosystem for data providers and AI model developers.